{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T10:40:00Z","timestamp":1773484800226,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/s41419-020-2412-5","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T13:02:45Z","timestamp":1586869365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Celiac disease TG2 autoantibodies development: it takes two to tango"],"prefix":"10.1038","volume":"11","author":[{"given":"Federica","family":"Rossin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Piacentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"2412_CR1","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1053\/j.gastro.2005.02.010","volume":"128","author":"DH Dewar","year":"2005","unstructured":"Dewar, D. H. & Ciclitira, P. J. Clinical features and diagnosis of celiac disease. Gastroenterology 128, S19\u2013S24 (2005).","journal-title":"Gastroenterology"},{"key":"2412_CR2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ajcn\/69.3.354","volume":"69","author":"JA Murray","year":"1999","unstructured":"Murray, J. A. The widening spectrum of celiac disease. Am. J. Clin. Nutr. 69, 354\u2013365 (1999).","journal-title":"Am. J. Clin. Nutr."},{"key":"2412_CR3","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.4049\/jimmunol.1601693","volume":"198","author":"B Jabri","year":"2017","unstructured":"Jabri, B. & Sollid, L. M. T cells in celiac disease. J. Immunol. 198, 3005\u20133014 (2017).","journal-title":"J. Immunol."},{"key":"2412_CR4","doi-asserted-by":"publisher","first-page":"34109","DOI":"10.1074\/jbc.M204521200","volume":"277","author":"B Fleckenstein","year":"2002","unstructured":"Fleckenstein, B. et al. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J. Biol. Chem. 277, 34109\u201334116 (2002).","journal-title":"J. Biol. Chem."},{"key":"2412_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1392-9","volume":"10","author":"L Maiuri","year":"2019","unstructured":"Maiuri, L., Villella, V. R., Piacentini, M., Raia, V. & Kroemer, G. Defective proteostasis in celiac disease as a new therapeutic target. Cell Death Dis. 10, 114 (2019).","journal-title":"Cell Death Dis."},{"key":"2412_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.150","volume":"7","author":"H Tatsukawa","year":"2016","unstructured":"Tatsukawa, H., Furutani, Y., Hitomi, K. & Kojima, S. Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death. Cell Death Dis. 7, e2244 (2016).","journal-title":"Cell Death Dis."},{"key":"2412_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1515\/hsz-2018-0217","volume":"400","author":"M D\u2019Eletto","year":"2019","unstructured":"D\u2019Eletto, M., Rossin, F., Fedorova, O., Farrace, M. G. & Piacentini, M. Transglutaminase type 2 in the regulation of proteostasis. Biol. Chem. 400, 125\u2013140 (2019).","journal-title":"Biol. Chem."},{"key":"2412_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nm0797-797","volume":"3","author":"W Dieterich","year":"1997","unstructured":"Dieterich, W. et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 3, 797\u2013801 (1997).","journal-title":"Nat. Med."},{"key":"2412_CR9","doi-asserted-by":"publisher","first-page":"E885","DOI":"10.3390\/jcm8060885","volume":"8","author":"A Singh","year":"2019","unstructured":"Singh, A., Pramanik, A., Acharya, P. & Makharia, G. K. Non-invasive biomarkers for celiac disease. J. Clin. Med. 8, E885 (2019).","journal-title":"J. Clin. Med."},{"key":"2412_CR10","doi-asserted-by":"publisher","first-page":"e20190860","DOI":"10.1084\/jem.20190860","volume":"217","author":"MF du Pr\u00e9","year":"2020","unstructured":"du Pr\u00e9, M. F. et al. B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2. J. Exp. Med. 217, e20190860 (2020).","journal-title":"J. Exp. Med."},{"key":"2412_CR11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1126\/science.1900950","volume":"251","author":"S Adelstein","year":"1991","unstructured":"Adelstein, S. et al. Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science 251, 1223\u20131225 (1991).","journal-title":"Science"},{"key":"2412_CR12","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.4049\/jimmunol.171.11.5890","volume":"171","author":"BD Aplin","year":"2003","unstructured":"Aplin, B. D. et al. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model. J. Immunol. 171, 5890\u20135900 (2003).","journal-title":"J. Immunol."},{"key":"2412_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/BF02623682","volume":"23","author":"HF Upchurch","year":"1987","unstructured":"Upchurch, H. F., Conway, E., Patterson, M. K. Jr, Birckbichler, P. J. & Maxwell, M. D. Cellular transglutaminase has affinity for extracellular matrix. In Vitro Cell. Dev. Biol. 23, 795\u2013800 (1987).","journal-title":"In Vitro Cell. Dev. Biol."},{"key":"2412_CR14","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1111\/j.1742-4658.2011.08346.x","volume":"278","author":"AM Belkin","year":"2011","unstructured":"Belkin, A. M. Extracellular TG2: emerging functions and regulation. FEBS J. 278, 4704\u20134716 (2011).","journal-title":"FEBS J."},{"key":"2412_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1210\/jcem-65-5-885","volume":"65","author":"A Kitahara","year":"1987","unstructured":"Kitahara, A. et al. Specific localization of tissue-type transglutaminase in adrenocorticotropin-producing cells of the human pituitary gland as demonstrated by immunohistochemistry. J. Clin. Endocrinol. Metab. 65, 885\u2013890 (1987).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2412_CR16","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1681\/ASN.2006070690","volume":"18","author":"TS Johnson","year":"2007","unstructured":"Johnson, T. S. et al. Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease. J. Am. Soc. Nephrol. 18, 3078\u20133088 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2412_CR17","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1053\/j.gastro.2009.01.007","volume":"136","author":"H Tatsukawa","year":"2009","unstructured":"Tatsukawa, H. et al. Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1. Gastroenterology 136, 1783\u20131795 (2009).","journal-title":"Gastroenterology"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2412-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2412-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2412-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T23:35:01Z","timestamp":1722728101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2412-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["2412"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2412-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]},"assertion":[{"value":"28 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"229"}}